Seeing Is Believing
Healthcare - Sector
DARE is currently covered by 3 analysts
Dare Bioscience's activity chart (see below) currently has 13 price targets and 30 ratings on display. The stock rating distribution of DARE is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 64.44% with an average time for these price targets to be met of 887.47 days.
Highest price target for DARE is $2, Lowest price target is $2.
Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 02-Dec-2025. First documented stock forecast 18-Aug-2016.
Currently out of the existing stock ratings of DARE, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2020
$12
10 months 2 days ago
(02-Dec-2025)
1/6 (16.67%)
$9.16 (322.54%)
1042
Hold Since 04-Sep-2025
$8
$6.6 (471.43%)
1 years 1 months ago
(04-Sep-2025)
1/2 (50%)
$5.87 (275.59%)
2316
Buy Since 18-Aug-2025
$11
$9.6 (685.71%)
1 years 1 months 16 days ago
(18-Aug-2025)
1/2 (50%)
$8.89 (421.33%)
203
Buy Since 30-Nov-2022
$13
$11.6 (828.57%)
$5
2 years 1 months 18 days ago
(16-Aug-2024)
2/3 (66.67%)
$9.43 (264.15%)
149
Buy Since 13-Aug-2021
$2
$0.17 (9.29%)
$3
3 years 1 months 5 days ago
(30-Aug-2023)
4/4 (100%)
$-6.52 (-76.53%)
856
What is DARE (Dare Bioscience) average time for price targets to be met?
Which analyst most recently updated their price target on DARE (Dare Bioscience)?
Which analyst has the most public recommendations on DARE (Dare Bioscience)?
Which analyst is the currently most bullish on DARE (Dare Bioscience)?
Which analyst is the currently most reserved on DARE (Dare Bioscience)?